DK1334367T3 - Metode til bestemmelse af startdosis for vitamin-D-forbindelser - Google Patents

Metode til bestemmelse af startdosis for vitamin-D-forbindelser

Info

Publication number
DK1334367T3
DK1334367T3 DK01981868T DK01981868T DK1334367T3 DK 1334367 T3 DK1334367 T3 DK 1334367T3 DK 01981868 T DK01981868 T DK 01981868T DK 01981868 T DK01981868 T DK 01981868T DK 1334367 T3 DK1334367 T3 DK 1334367T3
Authority
DK
Denmark
Prior art keywords
vitamin
compounds
starting dose
dose
determining starting
Prior art date
Application number
DK01981868T
Other languages
English (en)
Inventor
Michael J Amdahl
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1334367T3 publication Critical patent/DK1334367T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01981868T 2000-10-13 2001-10-12 Metode til bestemmelse af startdosis for vitamin-D-forbindelser DK1334367T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24012600P 2000-10-13 2000-10-13

Publications (1)

Publication Number Publication Date
DK1334367T3 true DK1334367T3 (da) 2006-10-09

Family

ID=22905214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01981868T DK1334367T3 (da) 2000-10-13 2001-10-12 Metode til bestemmelse af startdosis for vitamin-D-forbindelser

Country Status (12)

Country Link
US (1) US20030092686A1 (da)
EP (1) EP1334367B1 (da)
JP (1) JP2004532801A (da)
AT (1) ATE329268T1 (da)
AU (2) AU1348302A (da)
CA (1) CA2423316A1 (da)
CY (1) CY1106146T1 (da)
DE (1) DE60120458T2 (da)
DK (1) DK1334367T3 (da)
ES (1) ES2266276T3 (da)
PT (1) PT1334367E (da)
WO (1) WO2002031514A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100015246A1 (en) * 2000-06-27 2010-01-21 Shire International Licensing B.V. Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases
GB0015745D0 (en) * 2000-06-27 2000-08-16 Shire Holdings Ag Treatment of bone diseases
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5891868A (en) * 1997-11-21 1999-04-06 Kaiser Foundation Health Plan, Inc. Methods for treating postmenopausal women using ultra-low doses of estrogen
US6066091A (en) * 1998-02-23 2000-05-23 North Carolina State University Methods, systems and products for determining drug withdrawal intervals

Also Published As

Publication number Publication date
US20030092686A1 (en) 2003-05-15
EP1334367B1 (en) 2006-06-07
ATE329268T1 (de) 2006-06-15
JP2004532801A (ja) 2004-10-28
WO2002031514A3 (en) 2003-06-05
WO2002031514A2 (en) 2002-04-18
EP1334367A2 (en) 2003-08-13
DE60120458D1 (de) 2006-07-20
CA2423316A1 (en) 2002-04-18
AU2002213483B2 (en) 2007-03-29
PT1334367E (pt) 2006-10-31
AU1348302A (en) 2002-04-22
ES2266276T3 (es) 2007-03-01
DE60120458T2 (de) 2007-01-11
CY1106146T1 (el) 2011-06-08

Similar Documents

Publication Publication Date Title
BRPI0412684A (pt) compostos ppar-ativos
DE60219478D1 (en) Orale gabe von 6-hydroxy-oxymorphon als analgetikum
TR199800585T2 (xx) COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar.
AR066694A2 (es) Metodo para la preparacion de citalopram
ATE220896T1 (de) Hydrogelformulierung mit gesteuerter freisetzung
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
BR0312785A (pt) Tratamento de desordens relacionadas a tnf(alfa)
UY27751A1 (es) Método para la administración de un anticolinérgico por inhalación
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
BR9812837A (pt) Processo para fazer um composto, e, composto
EA199900373A2 (ru) Фармацевтические композиции
WO2002096363A3 (en) Method for treating fibrotic diseases or other indications
EA200001102A1 (ru) Способ синтеза ингибиторов сох-2 (циклооксигеназы-2)
DK1604674T3 (da) Anvendelse af myoblaster til fremstilling af et medikament til behandling af stressinkontinens
MXPA02012076A (es) Compuestos quimicos.
DK1222922T3 (da) Fremgangsmåde til stabilisering af benzimidazolforbindelser
DK1423381T3 (da) 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
DK1274414T3 (da) Nasal administration af Metocloropramid til behandling af Gastroparese
DK0614366T3 (da) Anvendelse af creatinphosphat eller phosphoenolpyrodruesyre til behandling af tumorer
WO2002028880A8 (en) Compounds useful for treating hypertriglyceridemia
PT1334367E (pt) Metodo de determinacao da dose inicial de compostos de vitamina d
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
IS1801B (is) Pýridýlbisfosfónöt til notkunar sem efni til lækninga
WO2002096855A3 (en) Anticholinergic compounds and methods of use